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Background: RCTs in surgery are challenging owing to well established methodological issues. Well
designed pilot and feasibility studies (PFS) may help overcome such issues to inform successful main trial
design and conduct. This study aimed to analyse protocols of UK-funded studies to explore current use
of PFS in surgery and identify areas for practice improvement.
Methods: PFS of surgical interventions funded by UK National Institute for Health Research pro-
grammes from 2005 to 2015 were identified, and original study protocols and associated publications
sourced. Data extracted included study design characteristics, reasons for performing the work includ-
ing perceived uncertainties around conducting a definitive main trial, and whether the studies had been
published.
Results: Thirty-five surgical studies were identified, of which 29 were randomized, and over half (15
of 29) included additional methodological components (such as qualitative work examining recruitment,
and participant surveys studying current interventions). Most studies focused on uncertainties around
recruitment (32 of 35), with far fewer tackling uncertainties specific to surgery, such as intervention
stability, implementation or delivery (10 of 35). Only half (19 of 35) had made their results available
publicly, to date.
Conclusion: The full potential of pretrial work to inform and optimize definitive surgical studies is not
being realized.
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Introduction
High-quality RCTs are necessary to inform evidence-based
surgical practice. Surgical trials are challenging to do
owing to established methodological issues extending
beyond those of RCTs in other areas1–4. Challenges
specific to surgical RCTs include uncertainties around
the stability and/or standardization of the intervention,
selection and/or measurement of relevant clinical and
patient-reported outcomes, and issues surrounding patient
recruitment such as clinician and patient equipoise5–7.
These specific challenges, combined with surgeons’ lack
of familiarity with RCTs and the perception that par-
ticipation can be onerous, may mean that trials are not
initiated, conducted efficiently or completed on time and
on target.
Well designed pilot and feasibility studies (PFS) may
help to overcome challenges associated with undertaking
RCTs in surgery, by allowing uncertainties to be addressed,
and optimal design of the main trial to be determined8–10.
Previous methodological work has considered the use
and misuse of PFS in general. Several checklists have
been developed11–16 to identify and categorize specific
reasons for undertaking pilot work, with the aim of guiding
researchers into considering these for their study. More
recently, guidelines for improved reporting of PFS, in
the form of an extension to the CONSORT statement17,
have been published. Integral to the development of these
guidelines was the publication of a conceptual framework18
to promote understanding by defining the purpose and
scope of different types of PFS in preparation for RCTs.
These guidelines were, however, mostly theoretical,
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with no specific recommendations for the use of PFS in
surgery.
Some published recommendations have provided more
practical guidance regarding the use of PFS in surgery. The
Medical Research Council (MRC) framework19 for devel-
oping and evaluating all complex interventions (defined as
interventions with multiple components acting both inde-
pendently and interdependently) includes surgery. Within
this framework, undertaking PFS before full-scale evalu-
ation of surgical interventions in a definitive trial is
considered vital preparatory work19. The IDEAL (Idea,
Development, Exploration, Assessment and Long-term
follow-up) framework20–22 also provides recommenda-
tions specific to the evaluation of novel surgical interven-
tions from first in man to long-term studies, and suggests
study designs and issues to be considered at each stage
of evaluation. Both the MRC and, more specifically for
surgery, the IDEAL recommendations discuss PFS as part
of a larger framework for the development and assessment
of new complex interventions, and list several elements of
the design of PFS.
Although PFS are thought to be beneficial and are
endorsed as part of the strategic guidance discussed, there
is uncertainty regarding exactly how they influence the
design and conduct of successful RCTs22. At a fundamental
level, published literature suggests that the wider surgical
community may not understand the concept of PFS, with
evidence of small, underpowered RCTs often mislabelled
as pilot or feasibility studies11,14,23. Such studies often fail
to address baseline feasibility issues such as considering
whether a main trial is possible, and instead focus on formal
hypothesis testing24–28. Further work is therefore needed
to understand when and how PFS may be used optimally
to inform future main trials in surgery.
Development of guidance that addresses the challenges
associated with undertaking surgical PFS requires under-
standing of the current use of such studies in surgery. As
PFS are often poorly reported, a traditional systematic
review of surgical PFS is unlikely to be informative beyond
what is already known. Major research funders are increas-
ingly recognizing the importance of well designed PFS
in informing main trial design. It was therefore hypothe-
sized that protocols of competitively funded PFS may pro-
vide more informative insights into the current use of PFS
in surgery, and into how pretrial work may be used to
inform future definitive studies. The aim of this paper was
to analyse protocols of successfully funded surgical PFS.
The purpose of this review was to identify how PFS are
currently used, consider whether their use is appropri-
ate, and envisage how the use of PFS could be further
improved.
Methods
A systematic analysis of the protocols of PFS of surgi-
cal interventions funded by the UK National Institute
for Health Research (NIHR) was undertaken.
Characteristics of information sources, search
strategy and screening
The UK NIHR Health Technology Assessment (HTA)
and Research for Patient Benefit (RfPB) programmes were
selected to identify PFS of surgical interventions. These
programmes are established major national funders of
high-quality patient-centred research, having funded trials
for 25 and 12 years respectively. Both programmes fund
definitive evaluations of the clinical and cost-effectiveness
of interventions, as well as feasibility studies to inform
future definitive trials. They have publicly available
and searchable databases of funded studies29,30. Given the
scope and longevity of both programmes, it was hypothe-
sized that each would have funded surgical PFS, providing
a sample of potentially well designed work from which to
explore the role of PFS in surgery, and study their impact
on main trial design and conduct.
The HTA and RfPB databases were searched for surgical
PFS. Titles and abstracts were screened in duplicate, with
any issues resolved by discussion and/or with senior input
where necessary. Agreement was reached on inclusion
or exclusion for 1283 studies (95⋅7 per cent) at the first
attempt. Protocols for all included HTA studies were
downloaded from the HTA website and those for all
included RfPB studies (apart from 1 available online)
were obtained by contacting the chief investigator of each
study directly. Additional publications relating to included
studies were identified by searching for links to published
outputs on the NIHR website (HTA only), and using
the study title, acronym and chief investigator name to
search on PubMed, Google Scholar and the ISRCTN
trials registry online.
Inclusion and exclusion criteria
Protocols of all surgical PFS funded by the NIHR HTA
and RfPB programmes between 1 January 2005 and 31
December 2015 were included. In the absence of uni-
versally adopted definitions of surgical interventions
and PFS, for the purposes of this review, pilot/feasibility
work was defined as: any research that is undertaken
before a main study and is explicitly intended to inform
the design and/or conduct of a future main study, where
main study is defined as a definitive study or RCT of an
intervention(s). A surgical intervention was defined as: a
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Fig. 1 Flow diagram showing selection of articles for review
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Total no. of studies included n=35
 Randomized n=29
 Non-randomized n=6
Studies excluded n=1
 Internal pilot study n=1
HTA studies
included
n=10
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included
n=25
Reasons for exclusion: 1, not a surgical intervention; 2, surgical intervention, not pilot/feasibility work; 3, surgical intervention is a co-intervention;
3a, surgical intervention is a co-intervention and not pilot/feasibility work. NIHR, National Institute for Health Research; HTA, Health Technology
Assessment; RfPB, Research for Patient Benefit.
diagnostic, therapeutic or adjunctive invasive intervention
performed by a trained clinician, using hands, instruments
and/or devices, and included operative, radiological and
endoscopic procedures.
Internal pilot studies were excluded owing to grow-
ing opinion among trial methodologists that internal
pilots do not meet the true definition of pilot studies31.
This is because internal pilots are very distinct from
external pilots in their methodology, being designed
and funded as a part of a main trial with all data gen-
erated from this first phase contributing to the final
analysis. Internal pilots are, therefore, most often used
when no substantive changes to key components of
the trial, such as the intervention or outcomes, are
anticipated. In addition, study protocols of RCTs with
an internal pilot phase usually include only limit-
ed detail regarding the internal pilot phase itself, such
as a list of proposed progression criteria. It was therefore
© 2019 The Authors. BJS published by John Wiley & Sons Ltd www.bjs.co.uk BJS
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considered that a review of trial protocols with an inte-
grated internal pilot phase would be of limited value for
the purpose of this work. Also excluded were funded sys-
tematic reviews that did not state any intention to inform
a future definitive study, and studies that focused on the
evaluation of co-interventions to surgery, for example the
administration of anaesthetic drugs, and postoperative
rehabilitation or enhanced recovery programmes. This
was because the primary focus of this work was to explore
the specific difficulties surrounding studies of surgical
interventions.
Data extraction and analyses
Data were extracted using a standard database developed
in Microsoft Excel® (Microsoft, Redmond, Washington,
USA), including general study characteristics, available
data sources in addition to the study protocol (published
papers) and the surgical specialty of the study. The data
extraction form is available in Appendix S1 (supporting
information). Details of the study design (randomized
or non-randomized; quantitative or qualitative) and con-
duct, including characteristics of the patient population,
were extracted. A framework was developed for capturing
the uncertainties and challenges regarding the viability
of a future main trial, informed by expert knowledge
and previous methodological work regarding the design,
definitions and reporting of PFS11–18,32–34, published
MRC guidelines19 and the IDEAL framework20,21. All
possible reasons identified for undertaking PFS were
grouped into five key domains: main trial design; logistics;
recruitment; intervention; and outcomes. The domains
were constructed and ordered according to how extraction
progressed, with cross-checking between authors. Special
consideration was given to uncertainties and challenges
considered more specific and/or relevant to surgical trials.
Results were analysed in Microsoft Excel®. Descriptive
statistics are reported with comparison between the HTA
and RfPB, and randomized and non-randomized cohorts
where relevant.
Results
Screening
A total of 1341 funded studies were identified (703 HTA
studies, 52⋅4 per cent), and 35 eligible studies (25 RfPB, 10
HTA)were included in the final analysis (Fig. 1). Additional
data sources were available for 25 of the 35 studies; these
included a published protocol paper for 13 of 35 studies
and a paper reporting the PFS findings for 19 (Fig. 2). Pub-
lication rates of the study protocols were similar between
Fig. 2 Data sources available for the pilot and feasibility studies
included in the review
Published protocol
n=9
Published results
n=9*
RfPB, sourced by
contact with CI
n=25
HTA, sourced via
NIHR website
n=10
Published protocol
n=4
Study protocols
n=35
Published results
n=10†
*Published in peer-reviewed journal. †Health Technology Assessment
(HTA) report+/– other paper(s) in peer-reviewed journal. RfPB, Research
for Patient Benefit; CI, chief investigator; NIHR, National Institute for
Health Research.
funders (HTA 4 of 10, RfPB 9 of 25), although the results
of HTA studies were published more often than those of
RfPB studies (HTA 10 of 10, RfPB 9 of 25).
Study characteristics
Some 29 of 35 studies were randomized and six were
non-randomized (Fig. 1), including qualitative work,
national audit and cohort studies (Table 1). Randomized
studies were more often multicentre and conducted by
larger trial teams than non-randomized studies. Over half
of the randomized studies (15 of 29) also included other
types of pretrial work.
Reasons for conducting pilot/feasibility studies
Reasons for performing PFS are summarized in Table 2.
Addressing uncertainties around trial recruitment was cited
as the most common reason (32 of 35 studies; RfPB 23 of
25,HTA 9 of 10), followed by the overarching aim to deter-
mine whether a main trial was possible or necessary (27 of
35 studies; RfPB 17 of 25, HTA 10 of 10). Logistical issues
(such as trial paperwork, resources needed, running mul-
ticentre studies) were considered in two-thirds of studies
(23 of 35 studies; RfPB 16 of 25, HTA 7 of 10) and out-
comes (for example selecting the primary outcome, deter-
mining important outcomes for patients) in less than half
(15 of 35 studies; RfPB 11 of 25, HTA 4 of 10). Around
half of the studies considered issues regarding the sample
size for the main trial (for example assessing variability in
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Table 1 Design characteristics of the 35 pilot/feasibility studies in the review
Randomized studies (n=29) Non-randomized studies (n=6)
RfPB (n=22) HTA (n=7) Total (n=29) HTA (n=3) RfPB (n=3) Total (n= 6)
Surgical specialty of study
Gastrointestinal 8 1 9 2 0 2
Urology 3 2 5 0 0 0
Cardiothoracic 3 0 3 0 0 0
Orthopaedic 2 2 4 0 0 0
Obstetrics/gynaecology 2 0 2 0 1 1
Maxillofacial/ENT 2 1 3 0 1 1
Plastics 1 0 1 0 0 0
Paediatrics 1 1 2 0 1 1
Breast 0 0 0 1 0 1
No. of centres* 3 (1–23) 4 (2–10) 3 (1–23) 1 (1) 2 (1–65) 1 (1–65)
1 7 0 7 3 1 4
2–20 14 7 21 0 1 1
>20 1 0 1 0 1 1
Proposed no. of participants in study* 50 (30–200) 70 (60–144) 60 (30–200) n.a. n.a. n.a.
Patient characteristics
Age
Adults 19 5 24 2 2 4
Children 2 1 3 1 0 1
Both 1 1 2 0 1 1
Sex
Male 1 1 2 0 0 0
Female 3 0 3 1 1 2
Both 18 6 24 2 2 4
Country
UK 20 7 27 2 3 5
Europe 2 0 2 0 0 0
Worldwide 0 0 0 1 0 1
No. of personnel in trial team* 6⋅5 (4–19) 9⋅5 (0–24) 9 (0–24) 1 (0–12) 7 (2–25) 5⋅5 (0–25)
Non-randomized pretrial work 9 6† 15† 3 3 6‡
Qualitative interviews 8 6 14 2 2 4
Participant/researcher survey 1 1 2 2 3 5
Economic modelling 0 1 1 0 0 0
Systematic review 0 0 0 1 0 1
National audit 0 0 0 0 1 1
Cohort study 0 0 0 0 1 1
*Values are median (range). †Some studies planned more than one type of non-randomized work; ‡most studies planned more than one type of
non-randomized work. RfPB, Research for Patient Benefit; HTA, Health Technology Assessment; ENT, ear, nose and throat; n.a., not applicable.
outcomes) (19 of 35 studies; RfPB 17 of 25, HTA 2 of 10)
and costs/funding for the main trial (16 of 35 studies; RfPB
14 of 25, HTA 2 of 10).
Eleven of the 35 studies (all RfPB-funded) aimed to
collect data regarding the safety or effectiveness of an
intervention to inform the main trial and, of these, almost
three-quarters (8 of 11) specified plans for formal hypoth-
esis testing by comparing the intervention(s) and/or
control groups to test effectiveness and/or safety, which is
not recommended for PFS.
One-quarter (10 of 35 studies; RfPB 6 of 25, HTA 4
of 10) sought to explore uncertainties around the surgi-
cal intervention itself, such as intervention development,
stability, delivery and the surgical learning curve. Of these
ten studies, six were considering surgery versus no surgery,
and four were considering a novel surgical technique versus
an established method (Table 3). Of the ten studies specif-
ically planning to evaluate a new surgical technique, only
four aimed to address uncertainties surrounding the inter-
vention. These uncertainties included: documenting the
© 2019 The Authors. BJS published by John Wiley & Sons Ltd www.bjs.co.uk BJS
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Table 2 Rationale as detailed in the protocol for the pilot and feasibility studies of surgical interventions included in the systematic
analysis
No. of studies stating each
rationale in the study protocol
No. of studies stating examination
of each area in the study protocol
Area examined Rationale
RfPB
(n =25) (3 NR)
HTA
(n =10) (3 NR)
Total
(n =35) (6 NR)
RfPB
(n =25)
HTA
(n =10) Total (n= 35)
Main trial design
Main trial possible
/necessary
To examine and test whether a main trial
is possible
14 (2) 8 (1) 22 (3)
To assess whether main trial is needed 3 (0) 0 (2) 3 (2)
and/or produce a protocol 17 10 27
To test whether the protocol can be
adhered to and modify it as necessary
2 (0) 2 (0) 4 (0)
Sample size To estimate the variability in outcomes 15 (1) 2 (0) 17 (1)
to help determine a sample size for
the main trial 17 2 19
To determine a sample size for the main
trial
3 (0) 0 (0) 3 (0)
Costs/funding To assess/gather information on costs
of performing the trial (direct and
indirect)
2 (0) 0 (0) 2 (0)
To perform/prepare for a 13 (1) 2 (0) 15 (1)
cost-effectiveness analysis of the
intervention(s) 14 2 16
To provide information/evidence to
funders
1 (0) 0 (0) 1 (0)
Safety and
effectiveness data
Preliminary data on safety to inform a
main trial
2 (0) 0 (0) 2 (0)
Information on adverse events 4 (0) 0 (0) 4 (0)
Planned formal hypothesis testing of 3 (1) 0 (0) 3 (1)
safety outcomes* 11 0 11
Preliminary data on effectiveness to
inform a main trial
0 (0) 0 (0) 0 (0)
Planned formal hypothesis testing of
effectiveness outcomes*
7 (1) 0 (0) 7 (1)
Logistics To test the logistics of multicentre
studies
5 (0) 1 (0) 6 (0)
To develop a research network as a
resource for a future main trial
1 (1) 0 (0) 1 (1)
To develop/test patient information
content/forms/methods of delivery
1 (0) 3 (0) 4 (0)
To develop/test data collection
forms/methods
13 (1) 6 (1) 19 (2)
To develop/test questionnaires/surveys 5 (0) 1 (0) 6 (0)
To test response rates to 0 (0) 0 (0) 0 (0)
questionnaires/surveys 16 7 23
To prepare/plan/assess monitoring
procedures
0 (0) 1 (0) 1 (0)
To determine what resources are
needed for a main trial (e.g.
funding/staff)
3 (0) 0 (0) 3 (0)
To assess the logistics of delivering an
intervention as part of a trial in the
NHS
1 (0) 0 (0) 1 (0)
To test (novel) methods of blinding 1 (0) 1 (0) 2 (0)
To assess proposed data analysis
techniques
1 (0) 1 (0) 2 (0)
To learn about the day-to-day running of
a trial
1 (0) 0 (0) 1 (0)
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Table 2 Continued
No. of studies stating each
rationale in the study protocol
No. of studies stating examination
of each area in the study protocol
Area examined Rationale
RfPB
(n =25) (3 NR)
HTA
(n =10) (3 NR)
Total
(n =35) (6 NR)
RfPB
(n =25)
HTA
(n =10) Total (n= 35)
Recruitment To test/modify
inclusion/exclusion/eligibility criteria
2 (0) 0 (1) 2 (1)
To estimate the expected prevalence or
rate of incident cases in the
population
1 (1) 1 (0) 2 (1)
To estimate the number to be screened
and proportions of eligible patients
9 (0) 3 (0) 12 (0)
To assess numbers/rates of recruitment 17 (0) 5 (0) 22 (0)
and consent 23 9 32
To test the randomization procedure 5 (0) 3 (0) 8 (0)
To test the acceptability of
randomization/trial design
12 (1) 5 (2) 17 (3)
To determine the acceptability of the
intervention to clinicians and patients
12 (1) 4 (2) 16 (3)
To assess rates of retention in the study 11 (0) 2 (0) 13 (0)
Intervention To assess and monitor the development
of an intervention and/or its stability
2 (1) 1 (0) 3 (1)
To develop and test the implementation
and delivery of the intervention
1 (0) 3 (0) 4 (0)
To train staff in delivery and assessment
procedures
1 (0) 0 (0) 1 (0)
To monitor the surgical learning curve 2 (1) 0 (0) 2 (1) 6 4 10
To test rates of crossover 0 (0) 1 (0) 1 (0)
To examine reasons for
non-adherence/crossover for the
main trial
2 (0) 0 (0) 2 (0)
To develop pathways and protocols for
co-interventions
0 (0) 0 (0) 0 (0)
Outcome To select the most appropriate primary
outcome measure
9 (1) 0 (0) 9 (1)
To develop and test a new outcome 0 (0) 0 (0) 0 (0)
measure 11 4 15
To determine
appropriate/important/suitability of
outcome measures for
patients/clinicians
3 (0) 4 (2) 7 (2)
Values in parentheses are number of non-randomized (NR) studies. *Formal hypothesis testing to demonstrate the safety and/or effectiveness of an
intervention is generally not recommended for pilot and feasibility studies because of the underpowered sample size (see discussion). RfPB, Research
for Patient Benefit; HTA, Health Technology Assessment; NHS, National Health Service.
Table 3 Type of trial for studies that examined details of the surgical intervention and those that did not
Studies examining the
intervention (n=10)
Studies not examining
the intervention (n=25) Total (n= 35)
Surgery versus no surgery 6 9 15
New/novel surgical technique versus surgery 4 6 10
Non-randomized pilot/feasibility work 0 5 5
Surgery versus surgery (both established techniques) 0 4 4
Surgery versus placebo and no surgery (2 arms) 0 1 1
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technical development of the new intervention to inform
the development of a competency assessment tool for sur-
geon performance evaluation before participation in the
main trial; considering the feasibility of training and imple-
menting the new technique; determining the variation in
the type of new procedure performed across the UK; and
considering the impact of the learning curve on adverse
outcomes to inform entry criteria for a main trial.
Discussion
This study demonstrated that the full potential of PFS
to address the uncertainties and challenges specific
to undertaking surgical trials is yet to be realized. The
reasons most often cited by authors for performing PFS
reflect the targeting of uncertainties generic to trials
in general, such as recruitment, and considering whether
a main trial is possible. Less than one-third of surgical
PFS explored challenges of specific relevance to designing
and conducting trials in surgery, such as uncertainties
around the stability or delivery of the surgical intervention
itself. Notably, of the ten studies aiming to evaluate a
novel surgical intervention, only four addressed uncer-
tainties surrounding the procedure, such as development
of the new intervention, implementation and delivery
of the intervention, and the effect of the surgical learning
curve. Of equal importance is the finding that the role
of PFS in surgery is still often misunderstood, with nearly
one-quarter of studies planning to conduct formal hypoth-
esis testing. Results of PFS in surgery are frequently
under-reported, with almost half not publishing the results
to date, despite themajority having completed before 2018.
These findings indicate that there is a need for guidance
regarding the scope and optimal use of PFS to promote
main trial success and prevent research waste.
There are several possible reasons for the findings
observed in this study. Conceivably, there may be confu-
sion among surgeons around the value of PFS. In addition,
it is possible that the design of PFS in funding applica-
tions is skewed towards reasons perceived as important
to funders, such as demonstrating adequate recruitment
and the feasibility of completing a main trial to time and
target. It is likely that most trialists would acknowledge
that recruitment is paramount to study success. However,
there may be a lack of awareness amongst applicants of the
many other potential uncertainties that can compromise
the success of a main trial, particularly those around the
intervention.
Previous guidance9,10,17–19,35,36 regarding the optimal
design and conduct of PFS has been theoretical or generic.
The IDEAL framework, for example, describes a pathway
for new surgical interventions from first in man (stage
1) to long-term study (stage 4), with stage 2a (devel-
opment) and 2b (exploration) studies considered to be
PFS, focusing on addressing uncertainties before stage
3 assessment in a definitive RCT. The initial IDEAL
publication21, however, was largely theoretical with little
practical guidance about how PFS should be performed.
Recently published updated IDEAL recommendations22
now provide some clarification regarding the role of PFS
in surgery as a result of recognition that the original
IDEAL guidance published in 200921 had little impact on
the design and conduct of surgical PFS37. The updated
IDEAL framework22 suggests several feasibility issues
to consider in stage 2a/2b studies, including estimating
effect size, defining intervention quality and standards,
evaluating learning curves, exploring subgroup differ-
ences, eliciting key stakeholder values and preferences, and
analysis of adverse events. This list is far from exhaustive.
The present analysis of protocols for NIHR-funded
surgical PFS indicates that there are import-
ant additional issues regarding the design and conduct
of surgical trials that may usefully be explored in PFS.
The findings of PFS are often not widely disseminated11.
This may reflect journal editors’ lack of appreciation of
the value of pilot work11,38 and concerns about the qual-
ity or methodological rigour of pilot work in general11.
Introduction of open-access journals focused specifically
on PFS such as Pilot and Feasibility Studies may address
this39. Researchers themselvesmay also fail to prioritize the
reporting and dissemination of findings from PFS, which
may be fuelled further by the decision to pursue (or not)
the main trial. Notably, however, all tenHTA-funded stud-
ies identified in this review published their results. This
is because studies funded by HTA are required to publish
a report in the peer-reviewed Health Technology Assessment
journal.
The scope of PFS in general has historically often been
narrow, focusing typically on issues relating to safety and
efficacy40,41 or recruitment42. A 2011 literature review14
of 50 pilot RCTs demonstrated that only 56 per cent of
the studies addressed methodological issues in any depth.
Another literature review11 of studies published between
2007 and 2008 found that up to 74 per cent of PFS per-
formed and reported hypothesis testing for one or more
variables (compared with 23 per cent (8 of 35) in the
present study). There is now general acceptance that any
suggestion of promise or significance should be reported
with caution, given the underpowered sample size of most
PFS13,15,32,43,44, and the present examination of protocols
perhaps demonstrates a growing, if not complete, under-
standing of this issue.
© 2019 The Authors. BJS published by John Wiley & Sons Ltd www.bjs.co.uk BJS
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This study demonstrated some key limitations of PFS
in surgery, but focused solely on studies funded by the
NIHR HTA and RfPB funding streams. Other NIHR
funding streams were considered but excluded as they do
not commonly fund surgical research. Of the 29 studies
funded via the 2012 NIHR-commissioned call for surgical
research45, for example, only four met the inclusion criteria
of the present study. These four studies were funded by the
RfPB programme and were therefore all included in this
work. Although the NIHR HTA and RfPB programmes
are the major funders of studies of surgical interventions
in the UK, it is accepted that there are charities, for
example the British Heart Foundation and Arthritis UK,
which may fund such work. However, this would have
been logistically challenging given that very few funders
make study protocols publicly available. Conversely, the
NIHR-funded protocols are likely to be of relatively high
quality so may provide an overly positive perception of the
quality of PFS in surgery.
Working collaboratively to design and perform pretrial
work can deliver surgical PFS in a cost-effective and timely
manner, and can advance the development of definitive
studies46. High-quality PFS may also be resource- and
cost-effective, preventing waste by averting futile main
trials, or providing information to improve the design and
conduct of the main trial47. The findings from this study
indicate, however, that PFS in surgery are not currently
used to their full potential.
Work is under way to incorporate the present study
findings into a wider methodological project to develop
guidelines to support surgical researchers in undertaking
PFS. These are likely to build on existing guidance from
the MRC, the IDEAL group and broader methodological
work, but focus specifically on surgical PFS. It will be
important to explore if and how PFS influence main trial
design and conduct. This will be achieved by following
these NIHR-funded PFS as they progress to main trials.
The guidelines aim to provide researchers with clear and
accessible information regarding how and when to under-
take PFS, detail the key features to consider when design-
ing and conducting PFS to inform a future main trial, and
emphasize the importance of working collaboratively with
trial methodologists to ensure that PFS address all uncer-
tainties around future trial conduct accurately and wholly.
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